The 4th U.S. Circuit Court of Appeals has blocked in Maryland a federal rule that would prohibit clinics that receive federal funding through the Title X program from referring patients to and sharing office space with abortion providers—setting up conflicting rulings on the regulation in federal courts, in today's bite-sized hospital and health industry news from Arizona, Tennessee, and Maryland.
AstraZeneca on Tuesday announced it has paused its Phase 3 clinical trials for its coronavirus vaccine candidate to investigate an illness that has developed in a trial participant, as it's unclear whether the illness is linked to the experimental vaccine. AstraZeneca said the pause is a "routine action which has to happen whenever there is a potentially unexplained illness in one of the trials, … ensuring we maintain the integrity of the trials."
Recent polls suggest that one-third or more of Americans might not be willing to get a coronavirus vaccine—leading FDA and drugmakers to take new, highly visible steps to reassure the American public. But some experts question whether their moves go far enough to ensure the credibility of the vaccine approval process.
Public health experts expect the United States will experience a second wave of new coronavirus infections in the fall and winter—but this second wave may look significantly different than the first. Here's how.
Many skin conditions present themselves differently on dark skin than light skin, yet most dermatologists are trained almost exclusively on white skin—meaning skin conditions among people of color often go undiagnosed or are diagnosed late, Roni Caryn Rabin reports for the New York Times.
Print All Daily Briefing Article from
Have a Question?
Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.